Washington Post
@washingtonpost·2.8M subscribers·24.8K videos
Pfizer CEO Albert Bourla talks development of coronavirus vaccine (Full Stream 8/6)
Posted
August 6, 2020
Views
6,889
Likes
41
Comments
36
Engagement
August 6, 2020
6,889
41
36
1.12%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
26:05Now PlayingWhen Albert Bourla took over as CEO of Pfizer in January 2019, he said he wanted the pharmaceutical giant to be a more focused, innovative, science-based company. Bourla now finds himself at the forefront of developing and testing a COVID-19 vaccine in partnership with Germany's BioNTech. Underway with a late-stage clinical trial for its vaccine, if successful, Pfizer said they could supply up to 100 million doses of the vaccine by the end of 2020. Bourla will discuss the timeline for a safe and effective vaccine and the state of the health industry during these uncertain times. Join Washington Post senior writer Frances Stead Sellers on Thursday, Aug. 6 at 2:00 p.m. ET.
Washington Post Live is the newsroom’s live journalism platform, featuring interviews with toplevel government officials, business leaders, cultural influencers and emerging voices on the most pressing issues driving the news cycle nationally and across the globe. From oneonone, newsmaker interviews to indepth multisegment programs, Washington Post Live brings The Post’s newsroom to life on stage. Subscribe to The Washington Post on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
